458 related articles for article (PubMed ID: 32912939)
1. HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.
Mccafferty K; Caplin B; Knight S; Hockings P; Wheeler D; Fan SL; Hulthe J; Kleta R; Ashman N; Papastefanou V; Mehta H; Salama A; Hadzovic S; Chowdhury TA; Jarl L; Unwin R; Challis B; Sundgren AK; Yaqoob MM
BMJ Open; 2020 Sep; 10(9):e033923. PubMed ID: 32912939
[TBL] [Abstract][Full Text] [Related]
2. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
[TBL] [Abstract][Full Text] [Related]
3. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
4. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
[TBL] [Abstract][Full Text] [Related]
5. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK.
González-Pérez A; Saez M; Vizcaya D; Lind M; Garcia Rodriguez L
BMJ Open Diabetes Res Care; 2021 Oct; 9(1):. PubMed ID: 34607828
[TBL] [Abstract][Full Text] [Related]
7. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
Yokoyama H; Araki SI; Kawai K; Yamazaki K; Shirabe SI; Sugimoto H; Minami M; Miyazawa I; Maegawa H;
Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
[TBL] [Abstract][Full Text] [Related]
8. Baseline Urine Albumin-to-Creatinine Ratio is Associated With Decline of Estimated Glomerular Filtration Rate in Patients Newly Diagnosed With Type 2 Diabetes Mellitus: An Observational 5-year Cohort Study.
Zhou L; Gao Y; Li M; Cai X; Zhu Y; Han X; Ji L
Endocr Pract; 2024 Feb; 30(2):107-112. PubMed ID: 37925156
[TBL] [Abstract][Full Text] [Related]
9. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
Helou N; Dwyer A; Shaha M; Zanchi A
JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
[TBL] [Abstract][Full Text] [Related]
12. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
Kavuru V; Senger RS; Robertson JL; Choudhury D
PeerJ; 2023; 11():e14879. PubMed ID: 36874959
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
Chen S; Chen L; Jiang H
Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Zerbini G; Lamacchia O; Nicolucci A; Pugliese G;
BMC Med; 2021 Mar; 19(1):66. PubMed ID: 33715620
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
[No Abstract] [Full Text] [Related]
16. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study.
Farah RI; Al-Sabbagh MQ; Momani MS; Albtoosh A; Arabiat M; Abdulraheem AM; Aljabiri H; Abufaraj M
BMC Nephrol; 2021 Jun; 22(1):223. PubMed ID: 34134654
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
Farah R; Alhajahjeh A; Nofal A; Hyasat TB; Abu Jabeh RAH; Suboh LT; Alhawari H; Momani MS; Jaber HJ; AlAwwa I
J Diabetes Complications; 2023 Jun; 37(6):108478. PubMed ID: 37084653
[TBL] [Abstract][Full Text] [Related]
18. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline in diabetic kidney disease (VA PTXRx): protocol for a pragmatic randomised controlled trial.
Leehey DJ; Carlson K; Reda DJ; Craig I; Clise C; Conner TA; Agarwal R; Kaufman JS; Anderson RJ; Lammie D; Huminik J; Polzin L; McBurney C; Huang GD; Emanuele NV
BMJ Open; 2021 Aug; 11(8):e053019. PubMed ID: 34400461
[TBL] [Abstract][Full Text] [Related]
20. Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha I; Matias P; Mateus S; Aguiar F; Pereira P; Perneta Santos M; Costa R; Lourenço A; Guia J; Barata JD; Campos L
Nefrologia; 2016; 36(5):503-509. PubMed ID: 27445098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
